Evaluating a Novel Medication Device for Methadone Dosing

Evaluating a Novel Medication Device for Methadone Dosing

This study will evaluate whether a commercially available, secure, electronic pill box is a feasible, acceptable, and satisfactory method to manage take-home dosing of methadone for both methadone clinic patients and staff members.

Inclusion Criteria:

• 18 years or older
• Receiving methadone for the treatment of opioid use disorder for at least 90 days and having been on the same methadone dose for at least 30 days
• Have previously received a take-home dose of methadone as part of routine care
• Be willing to comply with the study schedule
• Be a methadone patient in the clinic within which this study is being conducted

Exclusion Criteria:

• Pregnancy
• Presence of an acute medical problems that requires immediate or intense medical management
• Presence of serious or unstable mental illness that interferes with study procedures
• Planning to leave methadone treatment within the next 12 weeks
• Being maintained on a dose of methadone that is less than 10mg or more than 100mg
• Currently receiving split doses of methadone as part of routine care